Smart + Strong.
All Rights Reserved.
Smart + Strong®
is a registered trademark of CDM Publishing, LLC.
The COVID-19 pandemic has profoundly disrupted almost every aspect of the battle against HIV.
Stroke is the number one killer of Americans—and nearly twice as common in Black Americans—but the effect of viral load hasn’t been clea...
HIV treatment usually requires daily pills, but longer-acting regimens are gaining ground.
However, it’s still unclear whether Undetectable = Untransmittable extends to breastmilk.
A 30-year retrospective review of abnormalities among infants born to women using antiretrovirals shows low, consistent levels.
At the current pace, only about 20% of the world’s population will be vaccinated by the end of 2021.
The woman has had an undetectable viral load and a normal CD4 count for more than 12 years after stopping antiretroviral therapy.
Injectable cabotegravir and rilpivirine are approved for people with viral suppression who would prefer monthly injections to daily pills.
A new long-acting injectables HIV drug shows promise in monkey study.
MK-8507, a long-acting NNRTI, will be tested in a weekly regimen with islatravir.
The HIV protease inhibitor combination did not speed recovery or reduce the risk of death in a large study.
The effect is greater for women, and it could have a detrimental effect on pregnancy outcomes at the population level.
Antiretroviral therapy helped people with the virus add years to their lives, but now scientists must address other issues of longevity.
The latest revision recognizes the importance of treatment as prevention.
The Miami program IDEA Exchange provides secure locations to store meds.
HIV and psoriasis
You have been inactive for 60 minutes and will be logged out in . Any updates not saved will be lost.
Click here to log back in.